ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Turning Point Therapeutics Inc

Turning Point Therapeutics Inc (TPTX)

76.01
0.00
(0.00%)
Closed September 15 4:00PM
0.00
0.00
(0.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
76.01
Bid
71.11
Ask
72.20
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
76.01
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

TPTX Latest News

Bristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point Therapeutics

Bristol Myers Squibb (NYSE:BMY) and Turning Point Therapeutics, Inc. (NASDAQ:TPTX) (“Turning Point”) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust...

Turning Point Therapeutics Reports Second-Quarter 2022 Financial Results, Provides Operational Updates

Positive feedback from pre-new drug application (NDA) meeting with U.S. Food and Drug Administration (FDA) focused on TRIDENT-1 registrational study of repotrectinibInitiated the Phase 1b/2...

Turning Point Therapeutics Provides Regulatory Update for Repotrectinib for the Treatment of ROS1+ Advanced NSCLC

SAN DIEGO, July 27, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for...

Turning Point Therapeutics and MD Anderson Announce Strategic Alliance to Advance Precision Cancer Therapies

HOUSTON and SAN DIEGO, June 24, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted...

Turning Point Therapeutics Shares Surge on Bristol Myers Deal

By Colin Kellaher Shares of Turning Point Therapeutics Inc. took flight on Friday after the clinical-stage precision-oncology company agreed to be acquired by Bristol Myers Squibb Co. for $4.1...

Bristol Myers to Buy Turning Point Therapeutics for $4.1 Billion

By Colin Kellaher Bristol Myers Squibb Co. on Friday said it agreed to buy clinical-stage precision-oncology company Turning Point Therapeutics Inc. for $4.1 billion, or $76 a share, in cash. The...

Turning Point Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for...

Turning Point Therapeutics Announces Appointment of Steve Sabus as Chief Commercial Officer

SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for...

Turning Point Therapeutics Reports First-Quarter 2022 Financial Results, Provides Operational Updates

Granted Third Breakthrough Therapy Designation (BTD) for Repotrectinib for the treatment of patients with ROS1-positive Metastatic NSCLC who have been Previously Treated with One ROS1 TKI and who...

Turning Point Gets Another FDA Breakthrough Designation for Repotrectinib

By Colin Kellaher Turning Point Therapeutics Inc. on Tuesday said the U.S. Food and Drug Administration granted breakthrough-therapy designation to its lead drug candidate, repotrectinib, for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NOVVUNova Vision Acquisition Corporation
$ 41.00
(207.35%)
17.4k
NOVVNova Vision Acquisition Corporation
$ 37.0001
(200.08%)
202.75k
SMXSMX Security Matters Public Company
$ 5.85
(138.78%)
49.72M
OMICSingular Genomics Systems Inc
$ 12.38
(119.12%)
2.72M
TILInstill Bio Inc
$ 84.75
(82.41%)
3.76M
GSIWGarden Stage Ltd
$ 2.9693
(-75.66%)
4.21M
UPCUniverse Pharmaceuticals Inc
$ 0.55
(-67.07%)
29.83M
VMARVision Marine Technologies Inc
$ 0.77
(-48.67%)
30.61M
PRLDPrelude Therapeutics Inc
$ 2.775
(-42.55%)
2.49M
CNEYCN Energy Group Inc
$ 0.4335
(-37.17%)
4.79M
NVDANVIDIA Corporation
$ 119.10
(-0.03%)
225.83M
XXII22nd Century Group Inc
$ 0.3447
(28.00%)
168.56M
IMRXImmuneering Corporation
$ 2.02
(41.26%)
131.85M
SQQQProShares UltraPro Short QQQ
$ 8.17
(-1.33%)
122.46M
MULNMullen Automotive Inc
$ 0.1328
(-20.48%)
119.52M

Discussion

View Full Feed
MasterBlastr MasterBlastr 3 minutes ago
Another completely nonsensical post, willfully ignorant of historical perspective.
NWBO
Ispro Ispro 4 minutes ago
Hopefully
FNMA
Swammmie1040 Swammmie1040 7 minutes ago
I also asked him and got a response about a projection of the saltwater pool PR for revenues per year and he gave me this answer

https://stocktwits.com/Swammie/message/586092546
SINC
Jack Torrance Jack Torrance 9 minutes ago
When I first learned about quantum computers years back, I instantly saw the future of personal computing ... and it's going to be quantum computers running on a cloud. People will no longer have a computer, per se. They will have a device that is a keyboard, with either a track pad or a mouse (user
IONQ
Swammmie1040 Swammmie1040 14 minutes ago
Email response to me from James about the Schwab situation $50 per trade

https://stocktwits.com/Swammie/message/586092505
SINC
Ace Trader Ace Trader 17 minutes ago
Great find !! Lets breakdown some things and open up where this could go!

Ok so we have a few hedge fund guys involved and endorsed the DJT campaign. Sounds like the wheels are turing and prepearing for Jan 6th??
So Questions for the board:

If you have Hedge fund
DJT
theorysuit theorysuit 18 minutes ago
Keep imagining sht kid. This will never sniff $3 (5.1B at 1.7B fully authorized) on UK without a plan for revenue (reiumbursement). How much does LP pay you to combat truth?


You only want longs to exit stage left so you can buy cheap shares at 3 bucks or so
NWBO
lakers17 lakers17 22 minutes ago
Yes, we do. Every company, especially the OTC, you look at management. These three are pretty bad, even for the OTC. Deadline after missed deadline. Podcast, cancelled, rescheduled, no biggie. Filings late except for one, no sweat. Paying off Vik, late and court was ignored, resulting in jud
NSAV
HANUMAN HANUMAN 22 minutes ago
A study shows that rising levels of brain protein Aß42, not the reduction of amyloid plaques, better explains the cognitive benefits of new Alzheimer’s drugs. This finding challenges the traditional focus on plaques in Alzheimer’s treatment.

A new study reveals that the rise in protei
SNPX
XenaLives XenaLives 24 minutes ago
The "gospel" according to "Hanibal"...

LOL !!!!!!!
XMaster2023 XMaster2023 24 minutes ago
Theory, Approval is NOT a pump. It is a major milestone! You only want longs to exit stage left so you can buy cheap shares at 3 bucks or so. Knowing of course within a year or two the share price will be 10 times the 3 bucks and that is being conservative as hell.

“There will be
NWBO
bigstocksnbonds bigstocksnbonds 26 minutes ago
It really has been a long year yes!!
wii1dr wii1dr 28 minutes ago
8/28/24 you said to Rick on this Post "WTF RICK". I rest my case.
KYNC
Tr8dervic Tr8dervic 28 minutes ago
GL Eli !

I'm in with 19 16 1 45

Stephen has 16 19 13 48

Dave has 16 5 8 2
fuagf fuagf 28 minutes ago
rooster, No we don't, take the Bible for example. The about
Trump may not be true, i'd guess it's more likely it is true.

"Oh because we all know books don’t lie! Lol"
dalesio_98 dalesio_98 29 minutes ago
Iron-eagle,

Seriously, your avatar now shows a picture of a Cassels lawyer with your comment below.

https://investorshub.advfn.com/uimage/uploads/2024/9/15/jwjmsScreenshot_20240915_010720_Chrome.jpg

Nope just turned my attention to the lawyers involved wi
Testpilot Testpilot 29 minutes ago
Yes indeed. Sister Sergeant used to go for walks with Smith and talk about the Lord. She personally witnessed creative miracles occur while ministering with Smith
CRTG

Your Recent History

Delayed Upgrade Clock